Nanotechnology shows early promise to treat cardiovascular disease

A new tactic in the battle against cardiovascular disease – employing nanoengineered molecules called "nanolipoblockers" as frontline infantry against harmful cholesterol – is showing promise in early laboratory studies at Rutgers, The State University of New Jersey.

In a paper scheduled for publication June 12 in the American Chemical Society's journal Biomacromolecules and now appearing on that journal's Web site, Rutgers researchers propose a way to combat clogged arteries by attacking how bad cholesterol triggers inflammation and causes plaque buildup at specific blood vessel sites. Their approach contrasts with today's statin drug therapy, which aims to reduce the amount of low density lipids, or LDLs ("bad" cholesterol), throughout the body.

In an ironic twist, the Rutgers approach aims to thwart a biological process that is typically beneficial and necessary. Prabhas Moghe, the principal investigator and associate professor of biomedical engineering and chemical and biochemical engineering at Rutgers, said that vascular plaque and inflammation develop when certain forms of LDL are attacked by white blood cells that scavenge cellular debris and disease agents. "While these scavengers, called macrophages, perform an essential role in keeping organisms healthy, their interaction with highly oxidized LDL molecules has quite the opposite effect," he said.

Moghe explains that macrophages accumulate large amounts of oxidized LDL and secrete chemicals that can damage the neighboring tissues and, ultimately, become fatty foam cells. The researchers' approach, therefore, is to create clusters of nanoengineered molecules that target specific receptor molecules on cell membranes and block these oxidized LDLs from attaching to macrophages.

Moghe is working with Kathryn Uhrich, Rutgers professor of chemistry and chemical biology, who is an expert at synthesizing biologically useful molecules at the nanoscale – anywhere from 10 to 100 nanometers long. The research team, which also includes graduate student Evangelia Chnari and synthetic chemists Lu Tian and Jinzhong Wang, has designed a family of nanolipoblockers, or NLBs, which compete with oxidized LDL for a macrophage's attention. The NLBs bind to a receptor sites on macrophages, cutting the accumulation of oxidized LDL by as much as 75 percent.

The NLB particles are made of several engineered organic strands or chains whose ends cluster around a central point, creating a structure known as a micelle. Uhrich synthesized molecule chains with several different characteristics, such as attracting or repelling water or having a positive or negative charge. When the chains assembled into micelles, Moghe tested them for how well they blocked LDL uptake.

"We're employing the tools of nanotechnology – specifically tailoring the structure of the molecule, changing groups on the ends of the chains and closely analyzing which forms of the particles bind to the different macrophage receptors," Uhrich said. "The significant finding of our study is that the nanoscale organization matters tremendously for blockage of oxidized LDL, which opens new avenues for more specific targeting of receptors."

Mogue said that if this method proves feasible in living organisms, it could convey treatment to the site of the problem, rather than a systemic approach. "While statins are a great stride in preventing cardiovascular disease, they are not suitable for everyone," Mogue said. "Our approach also has potential to topically address the recurrence of inflammation and blockage at stent surgery sites, something that systemically active drugs have not been shown to consistently do."

Research to test the performance of NPLs in living organisms is now under way.

Source: Rutgers, the State University of New Jersey

Related stories:

New blood test reveals risk for metabolic syndrome
University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome – which can lead to a considerably increased risk of developing heart disease.
Oxidative stress may predict later lung trouble in young adults
Markers of oxidative stress may predict future lung trouble, according to new research to be presented at the American Thoracic Society’s 2008 International Conference in Toronto on Wednesday, May 21.
More on mate tea: lower cholesterol and an international agreement
When a study in her lab showed that mate (mah’ tā) tea drinkers had experienced a significant increase in the activity of an enzyme that promotes HDL (good) cholesterol while lowering LDL (bad) cholesterol, University of Illinois scientist Elvira de Mejia headed for Argentina where mate tea has been grown and taken medicinally for centuries.
Study links air pollution to clogged arteries
Got high cholesterol? You might want to stay away from air pollution. That’s the message of a new UCLA study linking diesel exhaust to atherosclerosis, or hardening of the arteries, which significantly increases one’s risk for heart attack and stroke.
Pistachios lower cholesterol, provide antioxidants
A handful of pistachios may lower cholesterol and provide the antioxidants usually found in leafy green vegetables and brightly colored fruit, according to a team of researchers.
Study Links Form of 'Bad' Cholesterol with Heart Attack Risk
A blood component called glycated LDL -- a form of low-density lipoprotein, the "bad" cholesterol, with a sugar molecule attached -- is known to be higher in diabetics than non-diabetics, and extensive research has shown that diabetics are at increased risk of a heart attack.
Cholesterol drugs lower risk of stroke for elderly too
Elderly people who take a cholesterol drug after a stroke or mini-stroke lower their risk of having another stroke just as much as younger people in the same situation, according to research published in the September 3, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.
Sex hormones link to heart risk
Men are more prone to – and likely to die of - heart disease compared with women of a similar age – and sex hormones are to blame, according to a new University of Leicester led study.

News discussion:

Nanotechnology news